ADC Therapeutics SA (ADCT)
1.44
-0.16
(-10.00%)
USD |
NYSE |
Oct 23, 16:00
1.44
0.00 (0.00%)
After-Hours: 20:00
ADC Therapeutics Net Income (Quarterly) : -16.56M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.56M |
| March 31, 2026 | -32.97M |
| December 31, 2025 | -6.409M |
| September 30, 2025 | -40.97M |
| June 30, 2025 | -56.65M |
| March 31, 2025 | -38.60M |
| December 31, 2024 | -30.73M |
| September 30, 2024 | -43.97M |
| June 30, 2024 | -36.54M |
| March 31, 2024 | -46.61M |
| December 31, 2023 | -85.03M |
| September 30, 2023 | -46.73M |
| June 30, 2023 | -48.92M |
| Date | Value |
|---|---|
| March 31, 2023 | -59.37M |
| December 31, 2022 | -23.34M |
| September 30, 2022 | -50.61M |
| June 30, 2022 | -64.37M |
| March 31, 2022 | -16.66M |
| December 31, 2021 | -34.38M |
| September 30, 2021 | -71.55M |
| June 30, 2021 | -72.57M |
| March 31, 2021 | -51.53M |
| December 31, 2020 | -55.93M |
| September 30, 2020 | -20.33M |
| June 30, 2020 | -126.56M |
| March 31, 2020 | -43.48M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 237.40M |
| AC Immune SA | 2.371M |
| CRISPR Therapeutics AG | -91.15M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 19.25M |
| Total Expenses (Quarterly) | 35.81M |
| EPS Diluted (Quarterly) | -0.1069 |
| Enterprise Value | 81.97M |
| Gross Profit Margin (Quarterly) | 87.80% |
| Profit Margin (Quarterly) | -86.06% |
| Earnings Yield | -46.08% |
| Normalized Earnings Yield | -57.45 |